Celularity secures strategic license deal worth up to $35M for biomaterials portfolio
Source: SeekingAlpha
2026-03-10 08:45:12 ET
More on Celularity
Read the full article on Seeking Alpha
For further details see:
Celularity secures strategic license deal worth up to $35M for biomaterials portfolio
Celularity Inc. Warrant
NASDAQ: CELUW
CELUW Trading
25.97% G/L:
$0.0097 Last:
2,945 Volume:
$0.009695 Open:
CELUW Latest News
March 12, 2026 08:30:00 am
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities
March 10, 2026 08:30:00 am
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy
February 10, 2026 08:30:00 am
Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses
CELUW Stock Data
$33,461,366
16,924,239
N/A
22
N/A
Biotechnology & Life Sciences
Healthcare
US
Florham Park
